IANNONE, ROSA FRANCESCA
 Distribuzione geografica
Continente #
EU - Europa 205
NA - Nord America 136
AS - Asia 48
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 391
Nazione #
US - Stati Uniti d'America 136
IE - Irlanda 85
SE - Svezia 54
SG - Singapore 26
UA - Ucraina 23
CN - Cina 18
DE - Germania 11
CZ - Repubblica Ceca 10
IT - Italia 8
FI - Finlandia 6
FR - Francia 4
GB - Regno Unito 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
IN - India 1
IR - Iran 1
MD - Moldavia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
VN - Vietnam 1
Totale 391
Città #
Dublin 85
Chandler 34
Nyköping 34
Singapore 21
Ashburn 13
Jacksonville 13
Brno 10
Los Angeles 9
Munich 8
Princeton 7
Wilmington 7
Helsinki 6
Beijing 4
Guangzhou 3
Shanghai 3
Chicago 2
Foggia 2
Guiyang 2
New York 2
Nuremberg 2
Paris 2
Washington 2
Bari 1
Boardman 1
Changsha 1
Chisinau 1
Clearwater 1
Delhi 1
Dongyang 1
Hangzhou 1
Hanover 1
Köpingebro 1
London 1
Milan 1
Naples 1
Phoenix 1
Rui'an 1
Santa Venerina 1
Seattle 1
Tappahannock 1
Taranto 1
Wellingborough 1
Wellington 1
Zhenjiang 1
Totale 293
Nome #
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis 54
What have multicentre registries across the world taught us about the disease features of systemic sclerosis? 53
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis - A EUSTAR analysis 52
Preliminary data on post market safety profiles of covid 19 vaccines in rheumatic diseases: Assessments on various vaccines in use, different rheumatic disease subtypes, and immunosuppressive therapies: A two-centers study 49
Factors predicting early discontinuation of methotrexate as a first-line treatment for rheumatoid arthritis in Italy: Results from the GISEA registry 47
Thoracic lymphadenopathy as possible predictor of the onset of interstitial lung disease in systemic sclerosis patients without lung involvement at baseline visit: A retrospective analysis 40
Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEA 40
Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium 28
Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry 21
Racial differences in systemic sclerosis disease presentation: A European Scleroderma Trials and Research group study 17
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 17
Real-world effectiveness and persistence of golimumab as second-line anti-TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO-BEYOND, a 12-month prospective observational study 11
Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: A EUSTAR database analysis 8
Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research 5
Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database 5
Totale 447
Categoria #
all - tutte 4.477
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.477


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 0 0 0 0 0 2 4 0 5 0 2 0
2020/202149 2 3 5 0 5 1 7 11 7 7 1 0
2021/202260 0 1 0 0 7 1 0 6 11 24 0 10
2022/2023205 14 11 12 5 9 20 0 22 92 5 13 2
2023/202479 4 3 6 6 8 12 0 1 0 6 7 26
2024/202541 15 5 4 13 4 0 0 0 0 0 0 0
Totale 447